Delivery Order SPE2DB22D1106-SPE2DB23FEXT0
Award Date 9/4/23
Potential Completion Date 9/5/23
Potential Value $6.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $843.78 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 mg/100 ml vials of ropivacaine hydrochloride injection. As the prime contractor, Amerisourcebergen will deliver 100 ml vials of the anesthetic to its facility in Conshohocken, Pennsylvania within the period of performance from August 23 to August 24, 2023. The order was placed under an existing DLA pharmaceuticals contract vehicle to support the agency's medical supply...
- The Defense Logistics Agency awarded a $3,077.90 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride, a long-acting local anesthetic. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between July 27-28, 2023. The prime contractor, Amerisourcebergen, is a pharmaceutical wholesaler and distributor that supports the medical supply needs of the Department of Defense...
- The Defense Logistics Agency awarded a $2,340 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride, a sterile injectable anesthetic. The contract calls for Amerisourcebergen to deliver 200 ml of the anesthetic from its facility in Conshohocken, Pennsylvania to an unknown customer by June 26, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain for...
- The Defense Logistics Agency awarded a $2,215.18 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride, a long-acting amide local anesthetic. Performance will take place in Conshohocken, Pennsylvania under the terms of the order, which runs from June 27, 2023 through June 28, 2023. The award was made using the DLA's indefinite-delivery/indefinite-quantity federal supply schedule contracting vehicle. No subcontractors or...
- The Defense Logistics Agency awarded a $4,324.60 firm fixed price delivery order to Amerisourcebergen Drug Corp for 400 mg/200 ml vials of ropivacaine hydrochloride injection 0.2%. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical product from its facility in Conshohocken, Pennsylvania to fulfill DLA's requirements. The single delivery is scheduled to take place between August 24-25, 2023. No subcontractors or set aside designations were indicated....
- The Defense Logistics Agency awarded a $122.51 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/20 ml vials of ropivacaine hydrochloride injection 0.5%. The single day contract is being performed in Conshohocken, Pennsylvania under the agency's pharmaceutical supply chain program. As the prime contractor, Amerisourcebergen Corporation will deliver the requested anesthetic to support Defense Department medical operations. No subcontractors or set aside designations...
- The Defense Logistics Agency Troop Support Medical awarded a $451.50 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 150 mg/30 ml vials of ropivacaine hydrochloride injection 0.5%. As the prime contractor, Amerisourcebergen Drug will deliver the local anesthetic to its place of performance in Conshohocken, Pennsylvania within the one day period of August 29-30, 2023. The delivery order was placed against an existing DLA medical supply vehicle and no...
- The Defense Logistics Agency awarded a $1,954.40 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 mg/20 ml vials of ropivacaine hydrochloride injection 1%. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order is for a single day of delivery on July 18, 2023 to fulfill DLA requirements, with no subcontractors involved. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this...
- The Defense Logistics Agency awarded a $3,869.49 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride injection 0.2%. The single day contract calls for Amerisourcebergen to deliver the anesthetic to its Conshohocken, Pennsylvania facility from September 5-6, 2023. As a major supplier of pharmaceuticals and medical supplies to the U.S. military and other government agencies, Amerisourcebergen was likely awarded this delivery...
- The Defense Logistics Agency awarded a $6,590.28 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride 0.2% injection. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the analgesic medication from its facility in Conshohocken, Pennsylvania to support Defense Logistics Agency programs. No subcontractors or set aside designations were identified. The single day period of performance...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB23FEXT0Delivery Order
The Defense Logistics Agency awarded a $6,486.90 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride, a long-acting amide local anesthetic. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between September 4-5, 2023. The order was placed under an existing DLA pharmaceuticals contract vehicle to supply anesthetics and other drug products in support of U.S. military treatment facilities worldwide. No subcontractors or set-aside designations were identified.
Generated 12/20/23, 5:16 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 9/4/23 |